Searched for
HIMADRI SPECIALITY CHEMICAL TARGET PRICE
Motilal Oswal initiates coverage on Himadri Speciality Chemical with Buy rating, pegs 39% upsideMotilal Oswal has initiated coverage on Himadri Speciality Chemical with a Buy rating and a target price of Rs 780, implying 38.7% upside. ...- Kalyan Jewellers shares jump 15% in 2 days as target prices go up to Rs 900. Should you buy?Kalyan Jewellers shares have rallied sharply over the two sessions after brokerages raised their target prices following strong Q2 earnings...
- Time to shed fear and think positive? 5 mid-cap stocks from different sectors with upside potential of up to 33%Mid-cap stocks tend to move more than large-caps. And that works both ways. They rise faster when the market is rising, and fall harder whe...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%The FPIs that were selling in the Indian market all these months mostly owned large-cap stocks. And as they sold them, it was that segment ...
- Can Nifty hit 28,000 before 2028? Citi raises target, sees $12 billion inflowsCiti Research has raised its Nifty 50 target to 28,000 by end-2027, implying 12% upside, citing easing oil prices, stronger foreign inflows...
- Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its t...
- Will Nifty's winning streak light up Muhurat trading? Check strategy and stock picks for festive gainsMuhurat Trading Stock picks 2026: Indian equities are experiencing a significant rally ahead of the Diwali Muhurat trading session on Novem...
- Muhurat Trading 2026: Which stocks to buy during special session today? Analysts list top technical picksInvestors are preparing for the Muhurat Trading session today, which marks the beginning of Samvat 2083. Stock exchanges BSE and NSE will h...
- Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28% in 1 year, according to analystsDespite the upbeat mood in the market, remember one thing: Valuations are still not cheap. Even after everything the market has been throug...
- For investors with a 3- to 5-year horizon: 5 mid-cap stocks from different sectors with upside potential of more than 19%A development worth noting is that there was net FII buying in five of the last six trading sessions. But it is still tentative, and cannot...
- Only 3.2% of working Indians trade stocks. Why Morgan Stanley likes NSEMorgan Stanley has initiated coverage of NSE with an overweight rating and a price target of Rs 2,315, citing its dominant market share, st...
- Missed Reliance Industries’ historic 12% one-day rally? Here’s what technical analysts are sayingReliance Industries experienced a remarkable increase in share price after reporting impressive Q2 earnings, which significantly boosted it...
- BSE, Infosys, CG Power and 6 others to watch: Motilal Oswal reveals 9 stock ratings and target prices after Q2 resultsMotilal Oswal’s latest calls on BSE, Infosys, Kotak Bank, Adani Ports, JSW Steel, Shriram Finance, Torrent Pharma, Tata Motors and CG Power...
- Tata Projects secures order from GSFC for acid complex in GujaratThe proposed complex will comprise a 600 metric tonnes per day (MTPD) phosphoric acid plant and a 1,800 metric tonnes per day (MTPD) sulphu...
- Smallcap stocks rally up to 21% in 2 days: Should you chase the rush or book profits?In the last two trading sessions, smallcap stocks have experienced an impressive resurgence, with certain stocks posting significant gains....
- MTAR Technologies among 4 stocks closing above VWAPFour Nifty500 stocks closed more than 2.5% above their respective volume-weighted average prices (VWAPs) on October 26, according to StockE...
- Two Trades for Today: A top pharma company for a 5.3% upmove, a mid-cap chemical maker’s stock for an almost 7% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Concurrent Losers: 13 stocks decline for 5 consecutive sessionsDuring this period, around 123 stocks in the BSE 500 index declined in each of the five sessions. Of these, we identified 13 stocks that fe...
- Himadri Speciality Chemicals plans Rs 1,613-cr capacity expansion across key businessesHimadri Speciality Chemicals Ltd is implementing a growth strategy focused on capacity expansion and investment. The company plans to inves...
Load More
